Elevation Oncology, Inc. (ELEV) Financials

ELEV Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 89.1 million 34.3 million
2023-09-30 100.0 million 37.6 million
2023-06-30 110.4 million 38.2 million
2023-03-31 76.9 million 43.1 million

ELEV Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -12.2 million 284000
2023-09-30 -13.4 million 843000
2023-06-30 -13.8 million 744000
2023-03-31 -16.8 million 1.5 million

ELEV Net Income

No data available :(

ELEV Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 83.1 million - -
2023-09-30 94.8 million - -
2023-06-30 107.9 million 29.8 million -
2023-03-31 73.9 million 29.6 million -

ELEV Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 42.4 million
2023-09-30 42.4 million
2023-06-30 27.6 million
2023-03-31 23.6 million

ELEV Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.7 million 3.3 million 10000
2023-09-30 - 7.4 million 3.5 million -
2023-06-30 - 6.0 million 3.8 million -
2023-03-31 - 7.3 million 4.3 million -

ELEV Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 10000
2023-09-30 - 9000
2023-06-30 - 10000
2023-03-31 - 10000

ELEV

Price: $4

52 week price:
0.36
5.89

Earnings Per Share: -1.34 USD

P/E Ratio: -1.43

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 9000

Market Capitalization: 230.1 million

Links: